Consequences of genetic manipulations of gonadotrophins and gonadotrophin receptors in mice;Conséquences des manipulations génétiques des gonadotrophines et des récepteurs des gonadotrophines chez la souris

Annales d'Endocrinologie

Volumn 71, Issue 3, 2010, Pages 170-176

  Peltoketo, H ^a   Rivero Muller A ^b   Ahtiainen, P ^b   Poutanen, M ^b   Huhtaniemi, I ^a,b  

^a IMPERIAL COLLEGE LONDON   (United Kingdom)

^b UNIVERSITY OF TURKU   (Finland)

Author keywords

Follicle stimulating hormone (FSH); G protein coupled receptor (GPCR) dimerisation; Gonadotrophin receptors; Gonadotrophins; Human chorionic gonadotrophin (hCG); Knockout (KO) Mice; Luteinising hormone (LH); Luteoma; Ovary; Pituitary; Prolactinoma; Testis; Transgenic (TG) mice

Indexed keywords

CHORIONIC GONADOTROPIN BETA SUBUNIT; ESTROGEN; ESTROGEN RECEPTOR; FOLLITROPIN RECEPTOR; G PROTEIN COUPLED RECEPTOR; GONADOTROPIN; GONADOTROPIN RECEPTOR; LUTEINIZING HORMONE; PROGESTERONE; PROGESTERONE RECEPTOR; PROLACTIN; PROTEIN LHCGR; UNCLASSIFIED DRUG;

ARTICLE; BREAST DEVELOPMENT; DEPLETION; ESTROGEN BLOOD LEVEL; FEMALE INFERTILITY; GENE OVEREXPRESSION; GENE TARGETING; GENETIC MANIPULATION; KNOCKOUT MOUSE; LUTEINIZING HORMONE BLOOD LEVEL; MOUSE; NONHUMAN; OVARY; OVARY FOLLICLE DEVELOPMENT; OVARY HYPERSTIMULATION; PHENOTYPE; PROGESTERONE BLOOD LEVEL; PROLACTIN BLOOD LEVEL; PROLACTINOMA; TERATOMA; TRANSGENIC MOUSE;

ANIMALS; ESTRADIOL; FEMALE; FOLLICLE STIMULATING HORMONE; GONADOTROPIN-RELEASING HORMONE; GONADOTROPINS; HUMANS; MALE; MICE; MICE, KNOCKOUT; MICE, TRANSGENIC; OVARIAN DISEASES; RECEPTORS, FSH; RECEPTORS, GONADOTROPIN; RECEPTORS, LH;

EID: 77952743766     PISSN: 00034266     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.ando.2010.02.022     Document Type: Article

References (28)

1. Matzuk M.M., Lamb D.J. Genetic dissection of mammalian fertility pathways. Nature Cell Biol 2002, 4 Suppl:s41-s49.
2. Themmen A.P.N., Huhtaniemi I.T. Mutations of gonadotropins and gonadotropin receptors: elucidating the physiology and pathophysiology of pituitary-gonadal function. Endocr Rev 2000, 21:551-583.
3. Zhang F.P., Poutanen M., Wilbertz J., Huhtaniemi I. Normal prenatal but arrested postnatal sexual development of luteinizing hormone receptor knockout (LuRKO) mice. Mol Endocrinol 2001, 15:172-183.
4. Peltoketo H., Strauss L., Karjalainen R., Xhang M., Stamp G., Segaloff D., et al. Female mice expressing constitutively active mutants of FSH receptor with a phenotype of premature follicle depletion and estrogen access. Endocrinology 2010, [Epub ahead of print].
5. Rulli S.B., Ahtiainen P., Makela S., Toppari J., Poutanen M., Huhtaniemi I. Elevated steroidogenesis, defective reproductive organs, and infertility in transgenic male mice overexpressing human chorionic gonadotropin. Endocrinology 2003, 144:4980-4990.
6. Rulli S.B., Kuorelahti A., Karaer O., Pelliniemi L.J., Poutanen M., Huhtaniemi I. Reproductive disturbances, pituitary lactotrope adenomas, and mammary gland tumors in transgenic female mice producing high levels of human chorionic gonadotropin. Endocrinology 2002, 143:4084-4095.
7. Rivero-Müller A., Chou Y.-Y., Ji I., Lajic S., Hanyaloglu A.C., Jonas K., et al. Rescue of defective G-protein-coupled receptor function in vivo by intermolecular co-operation. Proc Natl Acad Sci U S A 2010, 107:2319-2324.
8. Ahtiainen P., Rulli S.B., Shariatmadari R., Pelliniemi L.J., Toppari J., Poutanen M., et al. Fetal but not adult Leydig cells are susceptible to adenoma formation in response to persistently high hCG level: a study on hCG overexpressing transgenic mice. Oncogene 2005, 24:7301-7309.
9. Kuorelahti A., Rulli S., Huhtaniemi I., Poutanen M. Human chorionic gonadotropin (hCG) up-regulates wnt5b and wnt7b in the mammary gland, and hCGbeta transgenic female mice present with mammary Gland tumors exhibiting characteristics of the Wnt/beta-catenin pathway activation. Endocrinology 2007, 148:3694-3703.
10. Yarram S.J., Perry M.J., Christopher T.J., Westby K., Brown N.L., Lamminen T., et al. Luteinizing hormone receptor knockout (LuRKO) mice and transgenic human chorionic gonadotropin (hCG)-overexpressing mice (hCG alphabeta+) have bone phenotypes. Endocrinology 2003, 144:3555-3564.
11. Miyoshi K., Rosner A., Nozawa M., Byrd C., Morgan F., Landesman-Bollag E., et al. Activation of different Wnt/beta-catenin signaling components in mammary epithelium induces transdifferentiation and the formation of pilar tumors. Oncogene 2002, 21(36):5548-5556.
12. McTavish K.J., Jimenez M., Walters K.A., Spaliviero J., Groome N.P., Themmen A.P., et al. Rising follicle-stimulating hormone levels with age accelerate female reproductive failure. Endocrinology 2007, 148:4432-4439.
13. Kumar T.R., Palapattu G., Wang P., Woodruff T.K., Boime I., Byrne M.C., et al. Transgenic models to study gonadotropin function: the role of follicle-stimulating hormone in gonadal growth and tumorigenesis. Mol Endocrinol 1999, 13:851-865.
14. Tomic D., Miller K.P., Kenny H.A., Woodruff T.K., Hoyer P., Flaws J.A. Ovarian follicle development requires Smad3. Mol Endocrinol 2004, 18:2224-2240.
15. Hunzicker-Dunn M., Maizels E.T. FSH signalling pathways in immature granulosa cells that regulate target gene expression: branching out from protein kinase A. Cell Signal 2006, 18:1351-1359.
16. Vassilatis D.K., Hohmann J.G., Zeng H., Li F., Ranchalis J.E., Mortrud M.T., et al. The G protein-coupled receptor repertoires of human and mouse. Proc Natl Acad Sci U S A. 2003, 100:4903-4908.
17. Pin J.P., Kniazeff J., Binet V., Liu J., Maurel D., Galvez T., et al. Activation mechanism of the heterodimeric GABA(B) receptor. Biochem Pharmacol 2004, 68:1565-1572.
18. Kaupmann K., Malitschek B., Schuler V., Heid J., Froestl W., Beck P., et al. GABA(B)-receptor subtypes assemble into functional heteromeric complexes. Nature 1998, 396:683-687.
19. Lee C., Ji I.J., Ji T.H. Use of defined-function mutants to access receptor-receptor interactions. Methods 2002, 27:318-323.
20. Lee C., Ji I., Ryu K., Song Y., Conn P.M., Ji T.H. Two defective heterozygous luteinizing hormone receptors can rescue hormone action. J Biol Chemi 2002, 277:15795-15800.
21. Ji I., Lee C., Jeoung M., Koo Y., Sievert G.A., Ji T.H. Trans-activation of mutant follicle-stimulating hormone receptors selectively generates only one of two hormone signals. Mol Endocrinol 2004, 18:968-978.
22. Zhang Y., Buchholz F., Muyrers J.P., Stewart A.F. A new logic for DNA engineering using recombination in Escherichia coli. Nature Genet 1998, 20:123-128.
23. Rivero-Muller A., Lajic S., Huhtaniemi I. Assisted large fragment insertion by Red/ET-recombination (ALFIRE) - an alternative and enhanced method for large fragment recombineering. Nucl Acid Res 2007, 35:e78.
24. Thomas K.R., Folger K.R., Capecchi M.R. High frequency targeting of genes to specific sites in the mammalian genome. Cell 1986, 44:419-428.
25. Darwin C. Mr. Darwin on vivisection. Nature 1881, 23:583.
26. Kumar T.R., Fairchild-Huntress V., Low M.J. Gonadotrope-specific expression of the human follicle-stimulating hormone beta-subunit gene in pituitaries of transgenic mice. Mol Endocrinol 1992, 6:81-90.
27. Haywood M., Tymchenko N., Spaliviero J., Koch A., Jimenez M., Gromoll J., et al. An activated human follicle-stimulating hormone (FSH) receptor stimulates FSH-like activity in gonadotropin-deficient transgenic mice. Mol Endocrinol 2002, 16:2582-2591.
28. Allan C.M., Lim P., Robson M., Spaliviero J., Handelsman D.J. Transgenic mutant D567G but not wild-type human FSH receptor overexpression provides FSH-independent and promiscuous glycoprotein hormone Sertoli cell signaling. Am J Physiol 2009, 296:E1022-E1028.